Results
1496
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
1,496 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
A178320 | ₩26,500.00 | -1.9% | 67.4% | ₩1.5t | ₩39,333.33 | PE28.7x | E52.1% | 0% | Tech | ||
HHR | AU$0.007 | 40.0% | -72.5% | AU$19.7m | n/a | PE6.7x | E102.6% | n/a | Energy | ||
AESI | US$21.10 | 3.9% | -1.9% | US$2.3b | US$26.33 | PE15.9x | E42.7% | 4.4% | Energy | ||
ONON | US$44.57 | 5.0% | 58.8% | US$14.3b | US$46.88 | PE78.5x | E24.4% | n/a | Consumer Durables | ||
LAVV3 | R$8.75 | 0.9% | 1.7% | R$1.7b | R$12.90 | PE6.3x | E21.2% | 3.2% | Real Estate Management and Development | ||
KEBNI B | SEK 1.44 | 0.6% | 8.9% | SEK 389.9m | SEK 2.20 | PS3.4x | E86.1% | n/a | Tech | ||
4480 | JP¥3,425.00 | 14.4% | -36.7% | JP¥111.3b | JP¥5,650.00 | PE41.4x | E30.5% | n/a | Healthcare | ||
CUV | AU$13.37 | -4.8% | -36.8% | AU$669.5m | AU$29.22 | PE22.2x | E28.1% | 0.4% | Pharmaceuticals & Biotech | ||
A179900 | ₩24,700.00 | -5.4% | 10.0% | ₩390.8b | ₩60,000.00 | PS19.4x | E122.7% | 0% | Tech | ||
A204620 | ₩3,695.00 | -6.1% | -36.9% | ₩209.8b | ₩7,233.33 | PS1.9x | E78.5% | n/a | Commercial Services | ||
CALTX | SEK 207.00 | 0.2% | 115.8% | SEK 11.2b | SEK 227.50 | PS7x | E51.9% | n/a | Pharmaceuticals & Biotech | ||
AV1 | AU$0.06 | 3.4% | 39.5% | AU$47.3m | n/a | PS14.6x | E103.9% | n/a | Software | ||
A067310 | ₩13,670.00 | -3.7% | -17.9% | ₩706.9b | ₩24,347.83 | PB2.4x | E97.4% | 0.3% | Semiconductors | ||
EH | US$15.30 | 27.8% | -14.4% | US$968.3m | US$25.41 | PS27.7x | E77.0% | n/a | Capital Goods | ||
PLT | AU$0.71 | 2.1% | 98.6% | AU$125.4m | AU$1.30 | PS1.7x | E106.4% | n/a | Diversified Financials | ||
A137400 | ₩54,200.00 | -1.5% | -19.8% | ₩1.3t | ₩85,350.00 | PE13.7x | E35.6% | 0% | Capital Goods | ||
CRDO | US$36.45 | 14.7% | 135.0% | US$6.0b | US$32.17 | PS31.2x | E60.9% | n/a | Semiconductors | ||
688408 | CN¥56.31 | 1.1% | 51.1% | CN¥10.9b | CN¥68.64 | PE24.5x | E26.9% | 1.0% | Capital Goods | ||
ADOC | €5.77 | 0.2% | -61.2% | €86.8m | €6.30 | PS14.3x | E63.0% | n/a | Pharmaceuticals & Biotech | ||
CTT | AU$1.31 | -5.4% | -50.0% | AU$596.8m | AU$3.12 | PE25.8x | E26.7% | n/a | Retail | ||
YGG | ฿1.02 | 18.6% | -87.0% | ฿614.0m | ฿10.75 | PS2.2x | E85.5% | 26.3% | Media | ||
505283 | ₹1,275.55 | -4.5% | 100.8% | ₹84.9b | ₹1,706.50 | PE58.1x | E30.1% | 0.5% | Capital Goods | ||
ACI | ₹790.80 | 3.1% | 21.7% | ₹98.9b | ₹832.17 | PE36.1x | E35.0% | 0.4% | Materials | ||
VOW | NOK 6.60 | -5.7% | -47.4% | NOK 751.3m | NOK 11.00 | PB1.9x | E97.7% | 0% | Commercial Services |